BL-7010
- Generic Name
- BL-7010
Safety and Systemic Exposure Study of BL-7010 in Well-Controlled Celiac Patients.
- First Posted Date
- 2013-11-25
- Last Posted Date
- 2017-08-18
- Lead Sponsor
- BioLineRx, Ltd.
- Target Recruit Count
- 40
- Registration Number
- NCT01990885
- Locations
- 🇫🇮
FinnMedi Clinical Trial Center, Tampere, Finland
🇫🇮CRST Clinical Research Services, Turku, Finland
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath